| 5-HT(2A) | serotonin 2A (receptor) |
| ACC | anterior cingulate cortex |
| ACTH | adrenocorticotropin |
| alpha-MSH | alpha-melanocyte-stimulating hormone |
| BBB | blood-brain barrier |
| CaV | voltage-gated Ca2+ channels |
| CCI | chronic constriction injury |
| CCK | cholecystokinin |
| CGRP | calcitonin gene-related peptide |
| CNS | central nervous system |
| DOP | δ-opioid peptide (receptor) |
| DRG | dorsal root ganglia |
| GPCR | GTP-binding protein (G protein)-coupled receptor |
| KOP | κ-opioid peptide (receptor) |
| MC4 | melanocortin type 4 (receptor) |
| mGlu1 | metabotropic glutamate 1 (receptor) |
| MOP | μ-opioid peptide (receptor) |
| MPEP | 2-Methyl-6-(phenylethynyl)pyridine hydrochloride |
| MSH | melanocyte stimulating hormone |
| N/OFQ | nociceptin/orphanin FQ |
| NK1 | neurokinin-1 (receptor) |
| NMDA | N-methyl-D-aspartate |
| NO | nitric oxide |
| NOP | nociceptin/orphanin FQ peptide (receptor) |
| NP | neuropathic pain |
| NTS1/2 | neurotensin subtype 1/2 (receptor) |
| OP | opioid pharmacophore |
| PAG | periaqueductal grey matter |
| PARS | poly(ADP-ribose) synthetase |
| PKC | protein kinase C |
| PNS | peripheral nervous system |
| POMC | proopiomelanocortin |
| RVM | rostral ventromedial medulla |
| SNL | sciatic nerve ligation |